Identification of a Risk Group For Gestational Hypertension in Pregnant Women Using a Questionnaire Method

Matyakubova S.A.

doi:10.51699/cajmns.v7i1.3106

Authors

Matyakubova S.A. Republican Specialized Scientific and Practical Center for Maternal and Child Health

DOI:

https://doi.org/10.51699/cajmns.v7i1.3106

Keywords:

blood pressure, gestational hypertension, pregnant women, questionnaire method

Abstract

Gestational arterial hypertension (GH) complicates 6–8% of pregnancies and remains one of the leading causes of maternal and perinatal morbidity and mortality worldwide. Early identification of pregnant women at risk for GH is therefore a key component of preventive obstetric care. The aim of this study was to identify a risk group for the development of gestational hypertension using a questionnaire-based screening method and to justify its inclusion in routine antenatal care.

A total of 957 pregnant women registered for childbirth at the 3rd family polyclinic in Urgench city were examined. The assessment was based on a structured questionnaire consisting of two sections that included demographic data and major risk factors for gestational hypertension. In addition, hemoglobin concentration, blood pressure parameters, body weight gain, and subjective symptoms were evaluated. Based on the total score obtained, pregnant women were stratified into low-, moderate-, and high-risk groups for GH development.

The results demonstrated that 17.7% of the examined women belonged to the risk group for gestational hypertension, with 9.1% classified as having a high probability of GH development. High attributable and relative risk values were associated with excessive body weight gain in the first trimester (>3 kg), elevated hemoglobin concentration (>120–130 g/L), absence of a physiological decrease in diastolic blood pressure, and sleep disturbances. The development of gestational hypertension was found to significantly influence pregnancy outcomes and delivery methods, being associated with a higher frequency of obstetric complications and operative deliveries.

The findings confirm the effectiveness of the questionnaire-based approach for early identification of pregnant women at increased risk of gestational hypertension. Implementation of this screening tool in routine antenatal practice may contribute to timely preventive measures and reduction of adverse maternal and perinatal outcomes.

References

L. V. Adamyan, N. V. Artymuk, N. V. Bashmakova, T. E. Belokrinnitskaya, S. R. Belomestnov, I. V. Bratishchev et al., Gipertenzivnye rasstroystva vo vremya beremennosti, v rodakh i v poslerodovom periode. Klinicheskie rekomendatsii (protokoly lecheniya). Moscow, Russia, 2016, 72 p.

G. T. Sukhikh and O. N. Tkacheva, Eds., Diagnostika i lechenie arterialnoy gipertonii u beremennykh. Moscow, Russia, 2011, 102 p.

I. E. Chazova, Yu. V. Zhernakova, E. V. Oshchepkova, S. A. Shalnova, E. B. Yarovaya, and A. O. Konradi et al., “Prevalence of cardiovascular risk factors in the Russian population of patients with arterial hypertension,” Kardiologiya, vol. 54, no. 10, pp. 4–12, 2014.

R. I. Stryuk, Yu. A. Bunin, V. M. Guryeva, O. B. Irtyuga, L. S. Kokov, and O. E. Kolomatskaya, “Diagnosis and treatment of cardiovascular diseases during pregnancy. National guidelines,” Russian Journal of Cardiology, vol. 23, no. 3, pp. 91–133, 2018, doi: 10.15829/1560-4071-2018-3-91-134.

National Clinical Protocol “Arterial Hypertension during Pregnancy”. Tashkent, Uzbekistan, 2021.

2018 ESC/ESH Guidelines for the management of arterial hypertension. European Society of Cardiology, 2018.

K. Kh. Khayitbaeva, “Immunological aspects in the genesis of autoimmune thyroiditis,” Journal of Theoretical and Clinical Medicine, no. 3, pp. 50–52, 2015.

R. Advani and S. Chandrasekaran, “Chronic hypertension diagnosed by the American Heart Association and American College of Cardiology criteria is associated with increased risk of developing hypertensive disorders of pregnancy,” American Journal of Obstetrics & Gynecology MFM, vol. 6, no. 3, p. 101269, Mar. 2024, doi: 10.1016/j.ajogmf.2023.101269.

D. Di Mascio, E. R. Magro-Malosso, G. Saccone, G. D. Marhefka, and V. Berghella, “Exercise during pregnancy in normal-weight women and risk of preterm birth: A systematic review and meta-analysis of randomized controlled trials,” American Journal of Obstetrics and Gynecology, vol. 215, no. 5, pp. 561–571, 2016.

“Health quality assessment of patients with toxic-diffuse goiter,” Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 4, pp. 7388–7394, 2020, doi: 10.37506/ijfmt.v14i4.12816.

G. J. Hofmeyr, T. A. Lawrie, Á. N. Atallah, and M. R. Torloni, “Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems,” Cochrane Database of Systematic Reviews, no. 10, CD001059, 2018.

S. I. Ismailov and K. K. Khayitboeva, “Problems of diagnostics and treatment of diffuse toxic goiter (Graves’ disease),” Vestnik of Saint Petersburg University. Medicine, vol. 14, no. 2, pp. 98–104, 2019, doi: 10.21638/spbu11.2019.202.

K. Kh. Khaitbaeva, “Gipertireoz (obzor literatury) [Hyperthyroidism: a literature review],” Journal of Theoretical and Clinical Medicine, no. 6, pp. 56–59, 2016.

M. Reddy, D. L. Rolnik, K. Harris, W. Li, B. W. Mol, F. Da Silva Costa et al., “Challenging the definition of hypertension in pregnancy: A retrospective cohort study,” American Journal of Obstetrics and Gynecology, vol. 222, no. 6, pp. 606.e1–606.e21, Jun. 2020, doi: 10.1016/j.ajog.2019.12.272.

L. J. Slade, H. D. Mistry, J. N. Bone, M. Wilson, M. Blackman, N. Syeda et al., “American College of Cardiology and American Heart Association blood pressure categories: A systematic review of the relationship with adverse pregnancy outcomes in the first half of pregnancy,” American Journal of Obstetrics and Gynecology, vol. 228, no. 4, pp. 418–429.e34, Apr. 2023, doi: 10.1016/j.ajog.2022.10.004.